Ray G. Butler
- 2 min read

#LungCancer Meets #DataScience in Barcelona

My infiltrated spy has just confirmed me that 7000+ clinical researchers and 50+ pharma companies working in lung cancer are right now in our city presenting their projects, clinical data and new products in the IASLC Conference.

If you are also one of those who can’t afford for a so-expensive ticket (1080€ just for walking around!) and you’re interested in how #DataScience techniques are being applied in this area just keep reading …

Speakers, sessions, posters and seminars

I downloaded the IASLC Conference app, searched for terms like “data exploration”, “data analytics” and “artificial intelligence” and collected this list of speakers, sessions, posters and seminars that I am pleased to share with you now.

# Exploratory Data Analysis

· EP1.04-44 - Exploration of Factors Relating to Paradoxical Immune Response in Patients Treated with Immune Checkpoint Inhibitors for NSCLC

· MS05.02 - Genetics Abnormalities in Chromatin Modifiers: Connection with MYC Pathway and Exploration for Therapeutics

· P1.01-73 - An Explorative Analysis of Pemetrexed +/- Pembrolizumab Maintenance from KEYNOTE-189 Versus PARAMOUNT, PRONOUNCE, and JVBL

· P2.01-78 - A Meta‑Analysis and Bioinformatics Exploration of the Prognostic Value of TP53 Co-Mutations in EGFR Mutated NSCLC

# Artificial Intelligence and Big Data

· EP1.17-02 - Artificial Intelligence in the Qualitative Study of Pulmonary Nodules by Analyzing the Genetic Map and Imaging Data of Lung Adenocarcinoma

· MA16.03 - Big Data Analysis for Personalized Medicine in Lung Cancer Patients

· P2.16-20 - Big Data and Survival Predictors in Lung Cancer Patients

· P2.01-78 - A Meta‑Analysis and Bioinformatics Exploration of the Prognostic Value of TP53 Co-Mutations in EGFR Mutated NSCLC

# Real World Data

· P1.16-17 - Getting to Know Our Weapons Better. Analyze from Real Life Data from León, Spain